CRESCENT BIOPHARMA INC.

Historical 13F Holders

Symbol
CBIO
CUSIP
G2545C104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for G2545C104 since 12/18/2024, largest first.

Filer % of Class Filed
Fairmount Funds Management LLC 13D/A
16.5% 7/20/2026
Event 7/16/2026
FMR LLC 13G/A
15.0% 2/5/2026
Event 12/31/2025
Biotechnology Value Fund L P 13G/A
10.0% 8/14/2025
Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P. 13G/A
9.5% 2/17/2026
Event 12/31/2025
ForGrowth III PA B.V. 13G
6.1% 12/11/2025
Event 12/8/2025
Vestal Point Capital, LP 13G
5.4% 2/17/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Tang Capital Management LLC 13G/A
4.2% 5/15/2026
Event 3/31/2026
Logos Global Management LP 13G/A
4.1% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 363 $5.30 k
2026 Q2 81 29.1 M $524 M
2026 Q1 60 25.1 M $461 M
2025 Q4 56 23.7 M $281 M
2025 Q3 42 11.3 M $135 M
2025 Q2 32 10.8 M $174 M